Clinical Trials List
2021-10-21 - 2023-10-27
Phase I/II
Recruiting3
Suspended1
-
Trial Applicant
OBI PHARMA, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- Yee Chao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 曾振輝 無
- 黃文冠 無
- 吳仁欽 無
- Jen-Shi Chen 無
- 蔡悅如 無
The Actual Total Number of Participants Enrolled
0 Suspended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
7 participants
-
Global
44 participants
